Applied Biosystems to Webcast Presentation at the 3rd Annual Leerink Swann Roundtable...

Applied Biosystems to Webcast Presentation at the 3rd Annual Leerink Swann Roundtable Conference on August 7

FOSTER CITY, Calif.--(Business Wire)--
Applied Biosystems Inc. (NYSE:ABI) announced today that it will
participate in the 3rd Annual Leerink Swann Roundtable Conference on
Emerging Products and Applications of Life Science Tools on Thursday,
August 7. Shaf Yousaf, Division President, MCB Genomic Analysis, will
discuss the Applied Biosystems SOLiD(TM) System for next-generation
genomic analysis and take questions from a Leerink Swann financial
analyst and attending investors. The live webcast is scheduled to
begin at 9:20 am ET. Immediately before his presentation Mr. Yousaf
also will participate in a panel discussion of emerging issues in
next-generation DNA sequencing.

Interested parties may access the live webcast and replay by
visiting the Investors section of the Applied Biosystems web site at
http://ir.appliedbiosystems.com. It is suggested that interested
parties access the webcast 15 minutes before the start of the live
webcast. The webcast replay will be archived on the Presentations page
of the Investors section of the website.

About Applied Biosystems

Applied Biosystems Inc. (formerly known as Applera Corporation) is
a global leader in the development and marketing of instrument-based
systems, consumables, software, and services for academic research,
the life science industry and commercial markets. Driven by its
employees' belief in the power of science to improve the human
condition, the company commercializes innovative technology solutions
for DNA, RNA, protein and small molecule analysis. Customers across
the disciplines of academic and clinical research, pharmaceutical
research and manufacturing, forensic DNA analysis, and agricultural
biotechnology use the company's tools and services to accelerate
scientific discovery, improve processes related to drug discovery and
development, detect potentially pathogenic microorganisms, and
identify individuals based on DNA sources. Applied Biosystems has a
comprehensive service and field applications support team for a global
installed base of high-performance genetic and protein analysis
solutions. Applied Biosystems Inc. has its corporate office in
Norwalk, CT. On June 12, 2008, Applera Corporation and Invitrogen
Corporation (NASDAQ:IVGN) announced that their Boards of Directors had
approved a definitive merger agreement under which Invitrogen will
acquire all of the outstanding shares of Applied Biosystems stock. The
merger is subject to customary closing conditions and is targeted to
close in the fall of 2008. Further information regarding the merger
will be provided in a joint proxy statement/prospectus to be mailed to
stockholders of the company and Invitrogen. Investors and security
holders are urged to read this document when it becomes available
because it will contain important information. Information about
Applied Biosystems, including reports and other information filed by
the company with the Securities and Exchange Commission, is available
at http://www.appliedbiosystems.com. All information in this news
release is as of the date of the release, and Applied Biosystems does
not undertake any duty to update this information unless required by
law.

(C)Copyright 2008. Applied Biosystems Inc. All rights reserved.
Applera, Applied Biosystems, and AB (Design) are registered trademarks
of Applied Biosystems Inc. or its subsidiaries in the U.S. and/or
certain other countries.

Applied Biosystems Inc.
William Craumer, 650-638-6382 (Investors)
william.craumer@appliedbiosystems.com

Copyright Business Wire 2008